Therapix Biosciences (TRPX) Reports Q2 Loss of $0.61
Tweet
Share
E-mailGet Alerts TRPX Hot Sheet
Join SI Premium – FREE
Therapix Biosciences (NASDAQ: TRPX) reported Q2 EPS of ($0.61).
For earnings history and earnings-related data on Therapix Biosciences (TRPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Elastic N.V. (ESTC) Tops Q1 EPS by 12c, Beats on Revenue; offers FY27 Guidance
- Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
